NCT03547115 2026-03-17A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AMLMEI Pharma, Inc.Phase 1 Terminated84 enrolled
NCT03990961 2026-02-20Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)University of ChicagoPhase 2 Terminated5 enrolled 11 charts